211 related articles for article (PubMed ID: 16524795)
1. [The effect of paclitaxel-eluting stents on restenosis].
Kurşaklioğlu H; Köz C; Iyisoy A; Ide T; Yildirim V; Töre HF; Işik E; Demirtaş E
Anadolu Kardiyol Derg; 2006 Mar; 6(1):18-23. PubMed ID: 16524795
[TBL] [Abstract][Full Text] [Related]
2. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
5. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW
J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249
[TBL] [Abstract][Full Text] [Related]
6. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404
[TBL] [Abstract][Full Text] [Related]
7. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Serruys PW; Sianos G; Abizaid A; Aoki J; den Heijer P; Bonnier H; Smits P; McClean D; Verheye S; Belardi J; Condado J; Pieper M; Gambone L; Bressers M; Symons J; Sousa E; Litvack F
J Am Coll Cardiol; 2005 Jul; 46(2):253-60. PubMed ID: 16022951
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of an antiallergic drug, pemirolast potassium, on restenosis after stent placement: quantitative coronary angiography and intravascular ultrasound studies.
Ohsawa H; Noike H; Kanai M; Hitsumoto T; Aoyagi K; Sakurai T; Sugiyama Y; Yoshinaga K; Kaku M; Matsumoto J; Iizuka T; Shimizu K; Takahashi M; Tomaru T; Sakuragawa H; Tokuhiro K
J Cardiol; 2003 Jul; 42(1):13-22. PubMed ID: 12892037
[TBL] [Abstract][Full Text] [Related]
9. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
[TBL] [Abstract][Full Text] [Related]
10. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
Speck U; Scheller B; Abramjuk C; Breitwieser C; Dobberstein J; Boehm M; Hamm B
Radiology; 2006 Aug; 240(2):411-8. PubMed ID: 16864669
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
[TBL] [Abstract][Full Text] [Related]
12. Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model.
Carter AJ; Wei W; Gibson L; Collingwood R; Tio F; Dooley J; Kopia GA
Cardiovasc Revasc Med; 2005; 6(2):58-64. PubMed ID: 16263360
[TBL] [Abstract][Full Text] [Related]
13. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries.
Jabara R; Chronos N; Tondato F; Conway D; Molema W; Park K; Mabin T; King S; Robinson K
J Invasive Cardiol; 2006 Aug; 18(8):383-90. PubMed ID: 16877788
[TBL] [Abstract][Full Text] [Related]
14. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
Min PK; Jung JH; Ko YG; Choi D; Jang Y; Shim WH
Circ J; 2007 Nov; 71(11):1685-90. PubMed ID: 17965485
[TBL] [Abstract][Full Text] [Related]
15. Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
Eshtehardi P; Cook S; Wandel S; Räber L; Wenaweser P; Togni M; Vogel R; Garachemani A; Eberli FR; Lüscher TF; Jüni P; Hess OM; Meier B; Windecker S
EuroIntervention; 2010 Sep; 6(4):467-74. PubMed ID: 20884434
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.
Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A;
Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus.
Kimura M; Mintz GS; Weissman NJ; Dawkins KD; Grube E; Ellis SG; Cannon LA; Masud Z; Mandinov L; Baim D; Stone GW
Am J Cardiol; 2008 May; 101(9):1263-8. PubMed ID: 18435955
[TBL] [Abstract][Full Text] [Related]
18. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
[TBL] [Abstract][Full Text] [Related]
19. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ
J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of restenosis in the canine coronary stents through local delivery of paclitaxel using the double-balloon perfusion catheter].
Wang JD; Yang TS; Sun ZJ; Guo J; Tian F; Chen YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Feb; 34(1):8-13. PubMed ID: 22737712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
